Botulinum toxin a for vulvodynia: a case report.
Vulvodynia is a poorly understood chronic pain condition, and patients who are refractory to standard therapies often pose a therapeutic dilemma. Current treatment modalities include antidepressants, anticonvulsants, biofeedback, pelvic floor physical therapy, and surgery; however, the options are limited for patients who fail to respond to these treatments. We present a case of refractory vulvodynia with severe dyspareunia successfully managed with a novel therapeutic approach combining botulinum toxin A and surgery.


CONCLUSIONS
The authors present a case of refractory vulvodynia that was successfully managed with a novel approach that combined botulinum toxin A and surgery.
Gunter
Jennifer
J
Department of Obstetrics and Gynecology, University of Colorado Health Sciences Center, Dever 80626, USA. jennifer.gunter@uchsc.edu
Brewer
Alan
A
Tawfik
Ossama
O
D000328:Adult; D001905:Botulinum Toxins / Q000627:therapeutic use*; D004414:Dyspareunia / Q000628:therapy; D005260:Female; D013509:Gynecologic Surgical Procedures; D006801:Humans; D010146:Pain / Q000209:etiology; D059408:Pain Management; D017773:Pelvic Floor / Q000473:pathology; D014844:Vulva / Q000473:pathology; D014845:Vulvar Diseases / Q000150:complications / Q000601:surgery / Q000628:therapy*
D001905:Botulinum Toxins